+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Viral Vectors And Plasmid DNA Global Market Report 2022: By Product, By Application, By Disease, By End-User

  • PDF Icon

    Report

  • 400 Pages
  • March 2022
  • Region: Global
  • The Business Research Company
  • ID: 5553749
Viral Vectors & Plasmid DNA Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global viral vectors & plasmid dna market.



This report focuses on viral vectors & plasmid dna market which is experiencing strong growth. The report gives a guide to the viral vectors & plasmid dna market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase


  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
  • Create regional and country strategies on the basis of local data and analysis
  • Identify growth segments for investment
  • Outperform competitors using forecast data and the drivers and trends shaping the market
  • Understand customers based on the latest market research findings
  • Benchmark performance against key competitors
  • Utilize the relationships between key data sets for superior strategizing
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for the viral vectors & plasmid dna? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Viral Vectors & Plasmid DNA market global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider viral vectors & plasmid dna market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth
  • Market segmentations break down market into sub markets
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers
  • The viral vectors & plasmid dna market section of the report gives context. It compares the viral vectors & plasmid dna market with other segments of the viral vectors & plasmid dna market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, viral vectors & plasmid dna indicators comparison

Scope


Markets Covered:


1) By Product: Plasmid DNA; Viral Vectors
2) By Application: Gene And Cancer Therapies; Viral Infections; Immunotherapy; Formulation Development; Others
3) By Disease: Infectious Diseases; Genetic Disorders; Cancer; Others
4) By End User: Research Institutes; Biopharmaceutical And Pharmaceutical Companies

Companies Mentioned: FUJIFILM Diosynth Biotechnologies; FinVector Vision Therapies; Lonza; Cobra Biologics and Pharmaceutical Services; Brammer Bio

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Frequently Asked Questions about the Global Viral Vectors & Plasmid DNA Market

What is the estimated value of the Global Viral Vectors & Plasmid DNA Market?

The Global Viral Vectors & Plasmid DNA Market was estimated to be valued at $0.8 billion in 2022.

What is the growth rate of the Global Viral Vectors & Plasmid DNA Market?

The growth rate of the Global Viral Vectors & Plasmid DNA Market is 14.6%, with an estimated value of $1.38 billion by 2026.

What is the forecasted size of the Global Viral Vectors & Plasmid DNA Market?

The Global Viral Vectors & Plasmid DNA Market is estimated to be worth $1.38 billion by 2026.

Who are the key companies in the Global Viral Vectors & Plasmid DNA Market?

Key companies in the Global Viral Vectors & Plasmid DNA Market include FUJIFILM Diosynth Biotechnologies, FinVector Vision Therapies, Lonza, Cobra Biologics and Pharmaceutical Services, Brammer Bio, Cell and Gene Therapy Catapult, VGXI, MassBiologics and Spark Therapeutics.

Table of Contents

1. Executive Summary2. Viral Vectors & Plasmid DNA Market Characteristics3. Viral Vectors & Plasmid DNA Market Trends And Strategies4. Impact Of COVID-19 On Viral Vectors & Plasmid DNA
5. Viral Vectors & Plasmid DNA Market Size And Growth
5.1. Global Viral Vectors & Plasmid DNA Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Viral Vectors & Plasmid DNA Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Viral Vectors & Plasmid DNA Market Segmentation
6.1. Global Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Plasmid DNA
  • Viral Vectors
6.2. Global Viral Vectors & Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Gene And Cancer Therapies
  • Viral Infections
  • Immunotherapy
  • Formulation Development
  • Others
6.3. Global Viral Vectors & Plasmid DNA Market, Segmentation By Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Infectious Diseases
  • Genetic Disorders
  • Cancer
  • Others
6.4. Global Viral Vectors & Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Research Institutes
  • Biopharmaceutical and Pharmaceutical Companies

7. Viral Vectors & Plasmid DNA Market Regional And Country Analysis
7.1. Global Viral Vectors & Plasmid DNA Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Viral Vectors & Plasmid DNA Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8. Asia-Pacific Viral Vectors & Plasmid DNA Market
8.1. Asia-Pacific Viral Vectors & Plasmid DNA Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. China Viral Vectors & Plasmid DNA Market
9.1. China Viral Vectors & Plasmid DNA Market Overview
9.2. China Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
10. India Viral Vectors & Plasmid DNA Market
10.1. India Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Japan Viral Vectors & Plasmid DNA Market
11.1. Japan Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. Australia Viral Vectors & Plasmid DNA Market
12.1. Australia Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Indonesia Viral Vectors & Plasmid DNA Market
13.1. Indonesia Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. South Korea Viral Vectors & Plasmid DNA Market
14.1. South Korea Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Western Europe Viral Vectors & Plasmid DNA Market
15.1. Western Europe Viral Vectors & Plasmid DNA Market Overview
15.2. Western Europe Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. UK Viral Vectors & Plasmid DNA Market
16.1. UK Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Germany Viral Vectors & Plasmid DNA Market
17.1. Germany Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. France Viral Vectors & Plasmid DNA Market
18.4. France Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.5. France Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. Eastern Europe Viral Vectors & Plasmid DNA Market
19.1. Eastern Europe Viral Vectors & Plasmid DNA Market Overview
19.2. Eastern Europe Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. Russia Viral Vectors & Plasmid DNA Market
20.1. Russia Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. North America Viral Vectors & Plasmid DNA Market
21.1. North America Viral Vectors & Plasmid DNA Market Overview
21.2. North America Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. USA Viral Vectors & Plasmid DNA Market
22.1. USA Viral Vectors & Plasmid DNA Market Overview
22.2. USA Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. South America Viral Vectors & Plasmid DNA Market
23.1. South America Viral Vectors & Plasmid DNA Market Overview
23.2. South America Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Brazil Viral Vectors & Plasmid DNA Market
24.1. Brazil Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Middle East Viral Vectors & Plasmid DNA Market
25.1. Middle East Viral Vectors & Plasmid DNA Market Overview
25.2. Middle East Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26. Africa Viral Vectors & Plasmid DNA Market
26.1. Africa Viral Vectors & Plasmid DNA Market Overview
26.2. Africa Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
27. Viral Vectors & Plasmid DNA Market Competitive Landscape And Company Profiles
27.1. Viral Vectors & Plasmid DNA Market Competitive Landscape
27.2. Viral Vectors & Plasmid DNA Market Company Profiles
27.2.1. FUJIFILM Diosynth Biotechnologies
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. FinVector Vision Therapies
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Lonza
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Cobra Biologics and Pharmaceutical Services
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Brammer Bio
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers And Acquisitions In The Viral Vectors & Plasmid DNA Market29. Viral Vectors & Plasmid DNA Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright And Disclaimer

Executive Summary

Major players in the viral vectors & plasmid DNA market are FUJIFILM Diosynth Biotechnologies, FinVector Vision Therapies, Lonza, Cobra Biologics and Pharmaceutical Services, Brammer Bio, ??n?k? ??r??r?t??n, Cell and Gene Therapy Catapult, VGXI and MassBiologics.

The global viral vectors & plasmid DNA market is expected to grow from $0.69 billion in 2021 to $0.80 billion in 2022 at a compound annual growth rate (CAGR) of 14.8%. The growth is mainly due to the outbreak of COVID-19 and requires targeted delivery of the drug to treat affected patients. The number of cases has been increasing resulting in a surge in demand for viral vectors & plasmid DNA. The market is expected to reach $1.38 billion in 2026 at a CAGR of 14.8%.

The viral vectors & plasmid DNA market consists of sales of viral vectors & plasmid DNA and related services. The viral vectors & plasmid DNA are used for the delivery of cellular therapies, like gene therapy and immunotherapy, and also for treating some viral infections. The viral vectors & plasmid DNA are used for formulation development in research and development labs. The viral vectors are genetically engineered viruses carrying viral RNA or DNA that is non-infectious but still contain viral promoters and transgene. The plasmid DNA is a double-stranded extrachromosomal and circular DNA sequence that is capable of replication using the host cell's replication system.

The main types of products in viral vectors & plasmid DNA are plasmid DNA and viral vectors. A plasmid is a single-stranded, circular DNA molecule which is different from the chromosomal DNA of a cell. Plasmids are found organically in bacterial cells as well as in certain eukaryotes. Plasmid genes frequently confer genetic benefits to bacteria, such as antibiotic resistance. The different diseases include infectious diseases, genetic disorders, cancer, others and is used in gene and cancer therapies, viral infections, immunotherapy, formulation development, others. The several sectors include research institutes, biopharmaceutical and pharmaceutical companies.

North America is the largest region in the iral vectors & plasmid DNA market in 2021. Middle East is expected to be the fastest growing region. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The rise in the global incidence of cancer is driving the viral vector & plasmid DNA market. The major causes for most cancers include obesity, smoking, alcohol, improper eating habits. According to American cancer society 2020, an estimated 1.8 million new cancer cases diagnosed and 606,520 cancer deaths in the United States. Furthermore, according to the American Cancer Society, in 2019, around 606,880 deaths were caused in USA due to prevalence of the cancer . The Cancer Research UK predicts that there will be 27.5 million new cases of cancer each year by 2040 . The rise in the global incidence of cancer is expected to boost the demand for the viral vectors and plasmid DNA market over coming years.

The unaffordable cost of gene therapies is a major challenge in the viral vectors & plasmid DNA market. The prices of gene therapies range between $0.2 million to $2.1 million. For instance, Gilead company's Yescarta is a gene therapy that costs around $0.3 million and Bluebird Bio's Letiglobin is another gene therapy costing around $2.1 million. The high price is due to various factors like government regulations, production costs, and so on. Therefore, the unaffordable cost of gene therapies is limiting the viral vector & plasmid DNA market growth.

In January 2020, Cognate Bioservices Inc, a US-based company skilled in cell and cell-mediated gene therapy products, acquired Cobra Biologics, specialized in providing manufacturing services for plasmid DNA and viral vector, for an undisclosed amount. The acquisition is expected to create a platform for the life cycle management of cell and gene therapy products. Cobra biologics is well established in the development and manufacture of a variety of viral vectors and DNA. The combined Cognate and Cobra expertise is expected to push both the businesses to a better position to respond to current and future market demand.

The countries covered in the viral vectors & plasmid DNA market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • FUJIFILM Diosynth Biotechnologies
  • FinVector Vision Therapies
  • Lonza
  • Cobra Biologics and Pharmaceutical Services
  • Brammer Bio
  • Cell and Gene Therapy Catapult
  • VGXI
  • MassBiologics
  • Sanofi
  • Spark Therapeutics
  • UniQure
  • Thermo Fisher Scientific
  • VIROVEK
  • SIRION Biotech GmbH
  • ALDEVRON
  • Oxford BioMedica
  • Plasmid Factory
  • Biovian
  • BioReliance
  • 4D Molecular Therapeutics
  • Renova Therapeutics
  • Shenzhen SiBiono GeneTech Co.
  • Vigene Biosciences inc.
  • Novasep
  • Genzyme Corporation
  • Oxford Gene Technology
  • Richter-Helm
  • MolMed

Methodology

Loading
LOADING...